Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 450 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $61.457 million which beat the analyst consensus estimate of $57.725 million by 6.46 percent. This is a 26.56 percent increase over sales of $48.560 million the same period last year.